Gemcitabine in Treating Children With Refractory Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of gemcitabine in treating children who have
refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.